A detailed history of Texas Yale Capital Corp. transactions in Abbott Laboratories stock. As of the latest transaction made, Texas Yale Capital Corp. holds 12,635 shares of ABT stock, worth $1.63 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,635
Previous 12,635 -0.0%
Holding current value
$1.63 Million
Previous $1.31 Million 9.76%
% of portfolio
0.06%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $10,073 - $11,244
100 Added 0.8%
12,635 $1.31 Million
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $20,808 - $22,982
190 Added 1.54%
12,535 $1.42 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $18,038 - $22,080
-200 Reduced 1.59%
12,345 $1.36 Million
Q3 2023

Nov 09, 2023

BUY
$95.53 - $114.62 $10,508 - $12,608
110 Added 0.88%
12,545 $1.21 Million
Q2 2023

Aug 03, 2023

SELL
$100.78 - $112.29 $1,914 - $2,133
-19 Reduced 0.15%
12,435 $1.36 Million
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $233,432 - $274,764
2,410 Added 23.99%
12,454 $1.26 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $450,584 - $528,604
4,740 Added 89.37%
10,044 $1.1 Million
Q3 2022

Nov 08, 2022

SELL
$96.76 - $112.03 $9,676 - $11,203
-100 Reduced 1.85%
5,304 $513,000
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $48,483 - $58,600
-475 Reduced 8.08%
5,404 $587,000
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $77,982 - $95,485
675 Added 12.97%
5,879 $827,000
Q2 2020

Jul 31, 2020

SELL
$76.57 - $98.0 $17,687 - $22,638
-231 Reduced 4.25%
5,204 $476,000
Q2 2019

Jul 24, 2019

SELL
$72.88 - $85.0 $396,102 - $461,975
-5,435 Reduced 50.0%
5,435 $457,000
Q1 2019

May 10, 2019

BUY
$66.22 - $80.06 $359,905 - $435,126
5,435 Added 100.0%
10,870 $868,000
Q2 2018

Aug 07, 2018

SELL
$57.57 - $63.54 $18,710 - $20,650
-325 Reduced 5.64%
5,435 $331,000
Q3 2017

Nov 08, 2017

BUY
$48.06 - $53.64 $276,825 - $308,966
5,760
5,760 $307,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Texas Yale Capital Corp. Portfolio

Follow Texas Yale Capital Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Yale Capital Corp., based on Form 13F filings with the SEC.

News

Stay updated on Texas Yale Capital Corp. with notifications on news.